In CNS drug development, timelines aren’t just project management benchmarks. They’re tied to corporate milestones, investor commitments, and ultimately, patients waiting for therapies that could change their lives. When a sponsor’s priorities evolve mid-trial, the difference between a CRO that adapts and one that falls behind can determine whether a program reaches its next stage of progression.
This is the story of a Phase IIa schizophrenia trial that called for bold execution at every turn, and exactly what that looks like in practice.
THE STARTING LINE: 60 DAYS TO FIRST PATIENT IN
An emerging venture-backed neuroscience biotech selected CRC to lead a two-part Phase IIa schizophrenia trial tied to a critical milestone: achieving first patient in (FPI) within 60 days of award. The program had no room for a slow start.
CRC activated and achieved FPI in six weeks.
That outcome was the direct result of long-standing site relationships, CNS-specific operational infrastructure, and a team that understood what the sponsor needed from day one.
EVOLVING PRIORITIES, ACCELERATED TIMELINES
As the study progressed, the sponsor’s corporate objectives shifted in ways that required rapid operational adaptation. Two significant changes came in close succession:
- The sponsor doubled the number of subjects to be randomized within a four-month period.
- The topline results deadline was advanced by five weeks to support critical corporate objectives.
CRC’s response was immediate: a full recalibration of study operations to meet the new targets without compromising data quality or execution stability.
OPERATIONAL AGILITY WITHOUT SACRIFICING QUALITY
To address the increased enrollment volume, CRC aligned with the sponsor on protocol adjustments, deployed additional recruitment resources, and collaborated with the site to expand clinic capacity including bed space, EEG rooms, and lab and exam facilities. All of this was executed on a compressed timeline, without disrupting study continuity.
Meeting the accelerated topline results deadline required a coordinated effort across CRC, the site, the sponsor, and vendor partners. CRC expanded on-site CRA monitoring support to maintain real-time source data verification and issue resolution. Vendors reduced turnaround times. CRC’s data management team delivered an expedited database lock with full data integrity intact.
THE OUTCOME: EVERY MILESTONE ACHIEVED
All subjects completed on time. The database lock was delivered on the accelerated schedule. Topline results reached the sponsor by the new deadline, enabling the corporate milestones the program was built upon.
High-quality data and strong operational execution supported positive study results, positioning the program for its next phase of development.
KEYS TO SUCCESS
- Transparent collaboration across sponsor, site, and CRO teams drove rapid, aligned decision-making at every critical juncture.
- Established site and vendor relationships enabled fast operational adjustments and efficient resource deployment when timelines tightened.
- Deep CNS expertise across CRC leadership, clinical teams, and scientific advisors supported rapid issue resolution without sacrificing scientific rigor.
WHY THIS MATTERS FOR SCHIZOPHRENIA RESEARCH
Schizophrenia trials are among the most operationally demanding in psychiatry. Patient populations require careful screening and retention. Endpoint assessments demand rigorous training, calibration, and oversight to protect data integrity. Sites need to be equipped, trained, and supported at a level that requires deep therapeutic familiarity.
CRC’s exclusive focus on CNS, now twenty years deep, means these aren’t unfamiliar challenges. CRC’s team has supported 20+ schizophrenia trials and four FDA approvals in the indication – and that accumulated knowledge shapes how the team approaches every collaboration, from first conversation through final deliverable.
Facing tight clinical timelines?
Tight clinical timelines are a reality for many CNS sponsors. The question is whether your CRO is built to adapt when priorities shift.
CRC has been purpose-built for CNS for twenty years. When timelines compress, CRC’s team adapts with the expertise, the relationships, and the commitment to data quality that sponsors can depend on.
